The Effect of Antihypertensive Medication Timing on Morbidity and Mortality
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3357 participants.
Also called NCT02990663
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,357 participants
- Sponsor
- Registry
-
NCT02990663
-
- Other papers using this trial's data
- Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02990663. Randomized; single masking; primary purpose treatment. Start 2017-03-31 (actual); primary completion 2023-12-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Antihypertensive Medication Timing on Morbidity and Mortality
- Condition
- Hypertension
- Intervention (Other)
- Use of blood pressure lowering medication at bedtime
- Intervention (Other)
- Use of blood pressure lowering medication in the morning
- Lead sponsor
- University of Alberta
- Collaborator
- Alberta Innovates Health Solutions
- Collaborator
- Alberta Health services
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct02990663- Content hash
46419de5ddd0f29b5b390ae0da82c264e96631e90d3f49818484d63a94ce03b8